FDA to authorize 3rd COVID-19 vaccine dose for immunocompromised people

On Thursday (Aug. 12), the U.S. Food and Drug Administration (FDA) is planning to authorize a third vaccine dose for people with weakened immune systems, according to recent news reports.

The FDA will update the emergency use authorizations for the two mRNA vaccines — Pfizer/BioNTech and Moderna —to include a third dose for immunocompromised patients. That would be the first authorization of a third dose in the U.S.,  according to NBC News, which first reported the news.

Source link